Abstract
Objective To examine trends and variations of caesarean section by economic status and type of healthcare facility in Arab countries in Middle East and North Africa (MENA).
Methods Secondary data analysis of nationally representative household surveys across nine Arab countries in MENA. The study population was women aged 15-49 years with a live birth in the two years preceding the survey. Temporal changes in the use of caesarean section in each of the nine countries were calculated using generalised linear models and presented as risk differences(RD) with 95% confidence intervals(95%CI). Caesarean section was disaggregated against household wealth index and type of healthcare facility.
Results Use of caesarean section ranged from 57.3% (95%CI:55.6–59.1%) in Egypt to 5.7% of births (95%CI:4.9–6.6%) in Yemen. Overall, the use of caesarean section has increased across the MENA region, except in Jordan, where there was no evidence of change (RD −2.3% (95%CI:-6.0–1.4%). Within all MENA countries, caesarean section use was highest in the richest quintile compared poorest quintile, for example, 43.8% (95%CI:38.0-47.6%) vs. 22.6% (95%CI:19.6-25.9%) in Iraq, respectively. Caesarean section was higher in private sector facilities compared to public sector: 21.8% (95%CI:18.2-25.9 %) vs. 15.7% (95%CI:13.3-18.4%) in Yemen, respectively.
Conclusion Variations in caesarean section exist within and between Arab countries, and it was more commonly used amongst the richest quintiles and in private healthcare facilities. The private sector has a prominent role in the trends. Urgent policies and interventions are required to address non-medically indicated intervention.
Competing Interest Statement
Professor Abdel-Fattah's full declaration is on his webpage https://www.abdn.ac.uk/iahs/research/obsgynae/profiles/m.abdelfattahuniversity All other authors have no conflicts of interest to report.
Funding Statement
No funding to report
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was a secondary data analysis of publically available MICS and DHS data. As a result, ethical approval from the American University of Beirut was not required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available at: https://mics.unicef.org/ & https://dhsprogram.com/data/
